Literature DB >> 3292408

Malarial parasites induce TNF production by macrophages.

C A Bate1, J Taverne, J H Playfair.   

Abstract

Mouse peritoneal macrophages incubated with erythrocytes infected with non-lethal or lethal variants of Plasmodium yoelii or with P. berghei, in the presence of polymyxin B to exclude the effects of any contaminating endotoxin, secreted a cytotoxic factor into the supernatant that was shown to be tumour necrosis factor (TNF). No differences were observed in the ability of the three types of parasite to induce TNF production, which was maximal in the range of 0.2-5 infected erythrocytes per macrophages. TNF production was equivalent to that induced by lipopolysaccharide (LPS) and was enhanced by pretreatment of the macrophages with interferon-gamma (IFN-gamma) or with indomethacin. Culture media containing parasite products also induced macrophages to secrete TNF. The activity withstood boiling and was inhibited by malaria-specific antisera. Since heat-stable antigens are present in the circulation of patients with malaria, they may induced the secretion of TNF, a mediator of endotoxic shock, which could contribute to the pathology of the disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292408      PMCID: PMC1384947     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  29 in total

1.  Multiple cross-reactivities amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria.

Authors:  R F Anders
Journal:  Parasite Immunol       Date:  1986-11       Impact factor: 2.280

2.  The release of antigens by Plasmodium falciparum.

Authors:  R J Wilson; R K Bartholomew
Journal:  Parasitology       Date:  1975-10       Impact factor: 3.234

3.  Evaluation of Plasmodium berghei for endotoxin by the Limulus lysate assay.

Authors:  S C Felton; R B Prior; V A Spagna; J P Kreier
Journal:  J Parasitol       Date:  1980-10       Impact factor: 1.276

4.  Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole.

Authors:  I A Clark; N H Hunt; G A Butcher; W B Cowden
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

5.  Tumor necrosis factor induction by Sendai virus.

Authors:  D Aderka; H Holtmann; L Toker; T Hahn; D Wallach
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

6.  Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro.

Authors:  J Taverne; J Tavernier; W Fiers; J H Playfair
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

7.  Possible importance of macrophage-derived mediators in acute malaria.

Authors:  I A Clark; J L Virelizier; E A Carswell; P R Wood
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

8.  Regulation of macrophage tumor necrosis factor production by prostaglandin E2.

Authors:  S L Kunkel; R C Wiggins; S W Chensue; J Larrick
Journal:  Biochem Biophys Res Commun       Date:  1986-05-29       Impact factor: 3.575

9.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

Authors:  B Beutler; N Krochin; I W Milsark; C Luedke; A Cerami
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

10.  Raised serum levels of tumour necrosis factor in parasitic infections.

Authors:  P Scuderi; K E Sterling; K S Lam; P R Finley; K J Ryan; C G Ray; E Petersen; D J Slymen; S E Salmon
Journal:  Lancet       Date:  1986-12-13       Impact factor: 79.321

View more
  51 in total

Review 1.  Regulation of tumor necrosis factor production by monocyte-macrophages and lymphocytes.

Authors:  G Trinchieri
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  Cytokines, thyroid autoantibody synthesis and thyroid cell survival in culture.

Authors:  S M McLachlan; J Taverne; M C Atherton; A Cooke; S Middleton; C A Pegg; F Clark; B Rees Smith
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

3.  Immunosuppressive function of hepatitis B antigens in vitro: role of endoribonuclease V as one potential trans inactivator for cytokines in macrophages and human hepatoma cells.

Authors:  C Jochum; R Voth; S Rossol; K H Meyer zum Büschenfelde; G Hess; H Will; H C Schröder; R Steffen; W E Müller
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

4.  A monoclonal antibody that recognizes phosphatidylinositol inhibits induction of tumor necrosis factor alpha by different strains of Plasmodium falciparum.

Authors:  C A Bate; D Kwiatkowski
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

5.  Stimulation of nitric oxide production in macrophages by Babesia bovis.

Authors:  R W Stich; L K Shoda; M Dreewes; B Adler; T W Jungi; W C Brown
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

6.  c-fos and tumor necrosis factor gene expression in Leishmania donovani-infected macrophages.

Authors:  A Descoteaux; G Matlashewski
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

7.  Ring-infected erythrocyte surface antigen (Pf/155RESA) induces tumour necrosis factor-alpha production.

Authors:  S Picot; F Peyron; P Deloron; C Boudin; B Chumpitazi; G Barbe; J P Vuillez; A Donadille; P Ambroise-Thomas
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

8.  Inhibitory immunoglobulin M antibodies to tumor necrosis factor-inducing toxins in patients with malaria.

Authors:  C A Bate; D Kwiatkowski
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

Review 9.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

10.  Immunization of mice with phosphatidylcholine drastically reduces the parasitaemia of subsequent Plasmodium chabaudi chabaudi blood-stage infections.

Authors:  G Bordmann; W Rudin; N Favre
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.